What is Sonic Hedgehog Medulloblastoma?

A medulloblastoma is a malignant tumor of the central nervous system. These tumors make up the overwhelming majority of embryonal brain tumors. They always arise in the posterior fossa of the brain, comprising about 40% of these tumors.

There are several subtypes based upon the molecular pathway affected as well as the conventional classification based on the histology. The type of cell in these tumors may be large cell/anaplastic, classic, desmoplastic/nodular, and medulloblastoma with extensive nodularity (MBEN).

The sonic hedgehog (SHH) subtype is the second most common subtype, making up about 27% of these tumors. However, when it comes to medulloblastomas in adults this is the most common, at about 58% of all subtypes put together. Most MBEN tumors show the SHH pathway. SHH medulloblastomas have a bimodal peak of incidence, being most frequently found to occur before the age of 4 years and after the age of 16 years. They are quite rare in children. It is a fact to note that SHH tumors occurring in childhood have a different genetic makeup compared to SHH tumors in adulthood, with MYCN gene amplifications and 10q deletions being common in childhood tumors.

The area from which they arise is typically located within the cerebellar hemispheres, on one side of the midline. SHH tumors are found to occur equally in males and females.

Dr. Aleksander Sekulic Explains the Hedgehog Pathway

Clinical Features

In most cases a medulloblastoma causes symptoms by blocking the flow of cerebrospinal fluid leading to its accumulation within the brain (called hydrocephalus). Some symptoms leading from this are:

  • Sudden headaches especially in the morning
  • Nausea with or without vomiting
  • Lethargy
  • Ataxia or unsteadiness of gait

In one of every five patients with medulloblastoma, hydrocephalus is absent and initial symptoms are due to cerebellar problems, such as appendicular ataxia and ipsilateral cranial nerve palsy of the sixth and seventh nerves.

The rarest and most catastrophic presentation of medulloblastoma is with acute lapse of consciousness and the onset of lethargy because of hemorrhage inside the tumor. The presentation in infants may include lethargy, delay in development and refusal or other difficulty with feeding. Cancer syndromes that may be associated with medulloblastoma include Turcot, Rubinstein-Taybi and Gorlin syndromes, among others.


The diagnosis of a medulloblastoma is based upon an evaluation of the symptoms and signs, with further testing including neurological examination to help localize the location of the tumor, imaging tests such as CT or MRI scans, and tissue biopsy. A cerebrospinal fluid tap is also helpful once the pressure within the brain is relieved.


A medulloblastoma is treated firstly by procedures to relieve the pressure within the brain by creating a shunt or alternative pathway, to help safe drainage of the accumulated fluid. Secondly, surgery is aimed at removing as much of the tumor as possible, and submitting the removed tissue to microscopic examination. The histology and molecular subtyping determines the following treatment based on the risk factors detected. Metastasis in the SHH subgroup occurs within the brain in about 17% of infants and 22% in children, but is much less frequent in adult life. Surgery is followed by chemotherapy and/or neuraxial radiation to prevent recurrence.

The outcome following treatment of an SHH medulloblastoma is intermediate in this whole group of tumors, with the overall survival being about 77% in infants, 51% in children and about 35% in adults. All histologic subtypes are not alike in their behavior, with some being more aggressive than others.

Further Reading

Last Updated: Feb 27, 2019

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2019, February 27). What is Sonic Hedgehog Medulloblastoma?. News-Medical. Retrieved on July 16, 2024 from https://www.news-medical.net/health/What-is-Sonic-Hedgehog-Medulloblastoma.aspx.

  • MLA

    Thomas, Liji. "What is Sonic Hedgehog Medulloblastoma?". News-Medical. 16 July 2024. <https://www.news-medical.net/health/What-is-Sonic-Hedgehog-Medulloblastoma.aspx>.

  • Chicago

    Thomas, Liji. "What is Sonic Hedgehog Medulloblastoma?". News-Medical. https://www.news-medical.net/health/What-is-Sonic-Hedgehog-Medulloblastoma.aspx. (accessed July 16, 2024).

  • Harvard

    Thomas, Liji. 2019. What is Sonic Hedgehog Medulloblastoma?. News-Medical, viewed 16 July 2024, https://www.news-medical.net/health/What-is-Sonic-Hedgehog-Medulloblastoma.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.